Kimberly Kraig Thompson - 07 Jul 2022 Form 4 Insider Report for Kraig Biocraft Laboratories, Inc (KBLB)

Role
CEO & CFO, Director, 10%+ Owner
Signature
/s/ Kim Thompson
Issuer symbol
KBLB
Transactions as of
07 Jul 2022
Net transactions value
$0
Form type
4
Filing time
11 Jul 2022, 16:30:37 UTC
Previous filing
07 Jul 2022
Next filing
13 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KBLB Common Stock Sale -20,000 -0.01% 202,039,324 07 Jul 2022 Direct F1, F3
transaction KBLB Common Stock Sale -40,000 -0.02% 201,999,324 08 Jul 2022 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares of the Issuer's Class A Common Stock were sold pursuant to the terms and formula set forth in Mr. Thompson's 10b5-1 trading plan dated February 26, 2019; such sales occurred on July 7, 2022 at $0.0588.
F2 These shares of the Issuer's Class A Common Stock were sold pursuant to the terms and formula set forth in Mr. Thompson's 10b5-1 trading plan dated February 26, 2019; such sales occurred on July 8, 2022 at $0.058.
F3 Includes 2 shares of common stock that may be issued upon conversion of the Series A Preferred Stock that are owned by Mr. Thompson, and the remainder consists of common stock Mr. Thompson owns.